| Study Outcomes | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance | |||||||||||||||||
|
Sign in to read for free
|
|||||||||||||||||
| Superior even skin tone and anti-ageing benefit of a combination of 4-hexylresorcinol and niacinamide | |||||||||||||||||
|
Sign in to read for free
|
|||||||||||||||||
| Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase | |||||||||||||||||
|
Sign in to read for free
|
|||||||||||||||||
| Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation | |||||||||||||||||
|
Sign in to read for free
|
|||||||||||||||||
| 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation | |||||||||||||||||
|
Sign in to read for free
|